Skip to main content
News

NHLBI Funding Opportunity Announcements, July 30, 2013

By July 31, 2013No Comments
nhlbi-logo-new.png

nhlbi-logo-new.png

Funding and Research Opportunities

The following funding opportunity announcements from the NHLBI or other components of the National Institutes of Health, might be of interest:

NIH Guide Notices:

NOT-HL-13-183: Notice of Information: NHLBI Will Only Accept Resubmitted Applications for the Extended Expiration Date for PAR-10-234 Bioengineering Research Partnerships (BRP)(R01)

  • The NHLBI will only accept resubmitted applications for the November 5, 2013 and January 7, 2014 (AIDS) standard due dates. Furthermore, all resubmission applications must come in on November 5, 2013 or January 7, 2014 (AIDS). NHLBI will not accept new, renewal or revision applications on November 5, 2013 and January 7, 2014.

NOT-OD-13-083: Extramural Loan Repayment Program for Pediatric Research (LRP-PR)

  • The NIH invites qualified health professionals who contractually agree to engage in NIH mission-relevant research for at least two years, and who agree to engage in such research for at least 20 hours per week based on a 40-hour work week, to apply for participation in the extramural LRP.

NOT-OD-13-081: Extramural Loan Repayment Program for Clinical Researchers (LRP-CR)

  • The NIH invites qualified health professionals who contractually agree to engage in NIH mission-relevant research for at least two years, and who agree to engage in such research for at least 20 hours per week based on a 40-hour work week, to apply for participation in the extramural LRP.

Request for Applications (RFA):

RFA-HL-14-001: Centers for Advanced Diagnostics and Experimental Therapeutics in Lung Diseases Stage II (CADET II)(UH2/UH3)

  • The purpose of this Funding Opportunity Announcement (FOA) is to invite applications for Centers for Advanced Diagnostics and Experimental Therapeutics in Lung Diseases Stage II (CADET II). The goal of the CADET program is to accelerate the development of novel products for the treatment of lung diseases and sleep disordered breathing using strategies based on relevant pathobiologic processes.

Leave a Reply

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.